G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2006
10/26/2006	WO2006064372A8 Method for identifying modulators of the activity of ion-channels receptors
10/26/2006	WO2006063703A3 Single nucleotide polymorphism (snp) associated to type ii diabetes
10/26/2006	WO2006063058A3 Small molecule inhibitors of bacterial dam dna methyl transferases
10/26/2006	WO2006050333A3 Methods and compositions for modulating apoptosis
10/26/2006	WO2006043081A3 Screening assay
10/26/2006	WO2006041759A3 Transgenic frog lines and assays employing them
10/26/2006	WO2006024476A3 Homogeneous method for determining an analyte in the presence of an excess of cross-reacting substances
10/26/2006	WO2006022882A3 Canine pancreatic lipse
10/26/2006	WO2006017428A3 Use of magnetic material to direct isolation of compounds and fractionation of multipart samples
10/26/2006	WO2006003330A3 Collections of traceable compounds and uses thereof
10/26/2006	WO2006002240A8 Computer systems and methods for constructing biological classifiers and uses thereof
10/26/2006	WO2005124352B1 Method for determining aggrecanase activities
10/26/2006	WO2005119261A3 Glut5 transporters expressed in cancer cells
10/26/2006	WO2005111609A3 Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
10/26/2006	WO2005103226A3 Plasma-enhanced functionalization of inorganic oxide surfaces
10/26/2006	WO2005090486A3 Surface modified carbon products and their applications
10/26/2006	WO2005086770A9 Methods for genetic analysis
10/26/2006	WO2005079840A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
10/26/2006	WO2005072314A3 Method and apparatus for evaluation of standing timber
10/26/2006	WO2005062788A3 Prostate specific proteins expressed in cancer and methods of use thereof
10/26/2006	WO2005054427A3 Target sequences for synthetic molecules
10/26/2006	WO2005020888A3 Compositions and methods of treating and diagnosing hepatoma
10/26/2006	WO2005011599A3 Antibodies specific for toxic amyloid beta protein oligomers
10/26/2006	WO2004106535A3 Enhanced cellular assay method for use in flow cytometry or similar instruments using optically resonant particles
10/26/2006	WO2004078995A3 Methods of modulating and of identifying agents that modulate intracellular calcium
10/26/2006	WO2003093789A3 Method for measuring ion channel activity
10/26/2006	WO2002101008A3 Intracellular signaling molecules
10/26/2006	US20060242724 Receptor
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241978 Electronic clinical chart system
10/26/2006	US20060241667 Tissue penetration device
10/26/2006	US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis
10/26/2006	US20060241139 Treatment of DNA damage related disorders
10/26/2006	US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
10/26/2006	US20060241036 Soluble human interleukin 18 receptor-alpha, method of assaying the same, assay kit and medicinal composition
10/26/2006	US20060241031 Assay
10/26/2006	US20060241023 Diabetic therapy; administering to patient an inhibitor of enzymatic conversion of fructose-lysine to fructose-lysine-3-phosphate
10/26/2006	US20060241015 Cancer genes
10/26/2006	US20060240573 Optical system including nanostructures for biological or chemical sensing
10/26/2006	US20060240572 System and method for Raman spectroscopy assay using paramagnetic particles
10/26/2006	US20060240571 Biosensors and methods for detecting agents based upon time resolved luminescent resonance energy transfer
10/26/2006	US20060240570 Cobalamin assay
10/26/2006	US20060240569 Semi-quantitative immunochromatographic device
10/26/2006	US20060240568 The sample receiving zone is coupled to the flow path; label specifically binds a target analyte; detection zone is coupled to the flow path and includes a region of interest and an immobilized test reagent that specifically binds the target analyte; reduced noise
10/26/2006	US20060240567 Method of immobilizing a protein to a zeolite
10/26/2006	US20060240564 pH gradient ion exchange LC-MS and mass compatible buffers
10/26/2006	US20060240563 Electronic system for tracking and monitoring articles to be sterilized and associated method
10/26/2006	US20060240562 Cleavable surfactants and methods of use thereof
10/26/2006	US20060240561 Biomarkers for diagnosing alzheimer's disease
10/26/2006	US20060240560 Microsphere optical ion sensors based on doped silica gel templates
10/26/2006	US20060240559 5-hydroxytryptamine transporter gene polymorphisms
10/26/2006	US20060240558 Photoelectrochemical determination of chemical oxygen demand
10/26/2006	US20060240557 Automated mechanical stress assay for screening cleaning ingredients
10/26/2006	US20060240553 Cultures of human CNS neural stem cells
10/26/2006	US20060240541 The sample receiving zone is coupled to the flow path; label specifically binds a target analyte; detection zone is coupled to the flow path and includes a region of interest and an immobilized test reagent that specifically binds the target analyte; reduced noise
10/26/2006	US20060240540 Biosensor, biosensor chip, and biosensor device
10/26/2006	US20060240523 Endogenous and non-endogenous versions of human G protein-coupled receptors
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240516 Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain
10/26/2006	US20060240507 Cationic anti-microbial peptides and methods of use thereof
10/26/2006	US20060240505 Identification of Targets of Antimicrobial Compounds
10/26/2006	US20060240503 Protease detection assay
10/26/2006	US20060240501 Removing fructosyl group from a fructosylated peptide or protein by reacting with an aqueous Pyrus pyrifolia, Vitis vinifera, or Daucus carota extract containing an enzyme that removes the fructose without removing an amino acid residue; detecting reaction products
10/26/2006	US20060240498 Devices and methods for detecting amniotic fluid in vaginal secretions
10/26/2006	US20060240497 Assaying apparatus, kit, and method for lipids and associated enzymes
10/26/2006	US20060240496 Immunogens, derivatives and immunoassay for ethyl glucuronide
10/26/2006	US20060240495 Non-invasive assessment of intra-amniotic environment
10/26/2006	US20060240494 Biocidal molecules, macromolecular targets and methods of production and use
10/26/2006	US20060240493 Cca1 as an antifungal target
10/26/2006	US20060240492 Carbon nanotube based immunosensors and methods of making and using
10/26/2006	US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/26/2006	US20060240490 Methods and compositions for identifying target cell cytolytic lymphocytes in a sample
10/26/2006	US20060240489 Carbodithioate ligands for nanotechnology and biosensing applications
10/26/2006	US20060240488 Detection of an immune response to GDF-8 modulating agents
10/26/2006	US20060240487 Detection of GDF-8 modulating agents
10/26/2006	US20060240486 Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
10/26/2006	US20060240485 Method of monitoring immunotherapy
10/26/2006	US20060240484 Protein for diagnosing diabetic retinopathy
10/26/2006	US20060240483 Inducing signalosome formation in cells, lysing and incubating the cell lysate on a solid phase coated with antibody capable of capturing the receptor within the signalosome, separating solid phase from the cell lysate, and detecting and measuring the amount of the protein bound to the solid phase
10/26/2006	US20060240482 Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
10/26/2006	US20060240480 Use of GFAP for identification of intracerebral hemorrhage
10/26/2006	US20060240479 Fluorescent Label
10/26/2006	US20060240478 Biosensor
10/26/2006	US20060240477 polypeptide comprising a symmetrical dimethylated arginine, is used for diagnosing systemic lupus erythematosus
10/26/2006	US20060240476 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor
10/26/2006	US20060240475 Detection of toxic gluten oligopeptides refractory to digestion by using antibodies and T cells responsive thereto; producing the antibodies by immunization of an animal
10/26/2006	US20060240474 Peptides able to switch between two structural states and their use
10/26/2006	US20060240472 Pigment protein
10/26/2006	US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product
10/26/2006	US20060240467 Analyte sampling element, analyte treatment device and analyte treatment method
10/26/2006	US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel
10/26/2006	US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
10/26/2006	US20060240455 Oxazine derivatives
10/26/2006	US20060240453 Clinically intelligent diagnostic devices and methods
10/26/2006	US20060240450 Genetic analysis for stratification of cancer risk
10/26/2006	US20060240446 Novel human cytomegalovirus DNA sequences
10/26/2006	US20060240444 Detection methods

1 ... 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 ... 3937